ut-logo website  
 
Log in
Express registration and login!
If you have a Facebook or LinkedIN account, use one of the buttons on the left to either login or create a new account.

Log in

 

Prostate Cancer Highlights

AUA 2011 - Effect of long-acting testosterone injections for treatment of hypogonadism after brachytherapy for prostate cancer - Session Highlight by Doron S. Stember, MD

WASHINGTON, DC USA (UroToday.com) - Despite historical concerns regarding testosterone replacement therapy (TRT) in any men with a history of prostate cancer, there is increasing awareness that it is safe in selected patients.

Read more...

AUA 2011 - Suprapubic vs. urethral catheter drainage following robot assisted radical prostatectomy: A matched analysis - Session Highlights

WASHINGTON, DC USA (UroToday.com) - This group looked at the long-term follow up (greater than 1 year) of over 300 patients who underwent robotic radical prostatectomy in which a suprapubic catheter was used for urinary drainage.

Read more...

AUA 2011 - Late breaking news: Denosumab to prevent bone metastases (Dmab 147 Study) - Session Highlights

WASHINGTON, DC USA (UroToday.com) - Denosumab interrupts the reciprocal interaction of tumor and bone cells.

Read more...

AUA 2011 - State-of-the-art lecture: Prostate cancer susceptibility genes - Session Highlights

WASHINGTON, DC USA (UroToday.com) - Dr. Kathleen Cooney discussed the analysis of families with high incidences of prostate cancer (CaP) that led to genetic analyses.

Read more...

AUA 2011 - State-of-the-art lecture: Risks of imaging and monitoring patients with urologic cancers - Session Highlights

WASHINGTON, DC USA (UroToday.com) - There are two types of risk, those of missing findings and those resulting from imaging.

Read more...

AUA 2011 - Effect of long-acting testosterone injections for treatment of hypogonadism after brachytherapy for prostate cancer - Session Highlights

WASHINGTON, DC USA (UroToday.com) -The research group evaluated the effect of long-acting testosterone injection for treatment of hypogonadism after brachytherapy for prostate cancer.

Read more...

AUA 2011 - State-of-the-art lecture: What is new in PSA based screening for prostate cancer - An update of the ERSPC study - Session Highlights

WASHINGTON, DC USA (UroToday.com) - A publication with 10 years follow-up is pending, but currently the data is embargoed.

Read more...

AUA 2011 - The VA/NCI/AHRQ CSP#407: Prostate Cancer Intervention Versus Observation Trial (PIVOT): Main results from a randomized trial comparing radical prostatectomy to watchful waiting in men with clinically localized prostate cancer - Session Highligh

WASHINGTON, DC USA (UroToday.com) - Dr. Timothy Wilt provided an update on the PIVOT trial; Prostate Cancer Intervention vs. Observation Trial.

Read more...

AUA 2011 - 5-alpha reductase inhibitors diminish the rate of progression in men with low risk prostate cancer on active surveillance - Session Highlights

WASHINGTON, DC USA (UroToday.com) - 5-alpha reductase inhibitors (5ARIs) are associated with a significantly lower rate of pathologic progression and abandonment of active surveillance, Dr. Antonio Finelli reported.

Read more...

Page 1 of 6